Internal Medicine, Rheumatology · Flint, MI
NPI
1952418410
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1311 S Linden Rd Ste C
Flint, MI, 48532
Phone (810) 230-2400
Groups this clinician bills Medicare through
Medicare paid, 2024
$104K
2,904 services
Medicare patients, 2024
482
Average age 73
Drug cost, 2024
$14.8M
7,262 prescriptions
Company payments, 2025
$1,341
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jolanta Sobotka-Czarnecki was code 85025 (blood count), 774 times for 411 patients. In total Jolanta Sobotka-Czarnecki billed 2,904 services in 29 codes, and Medicare paid $104K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 85025 Blood Count | Office | 774 | 411 | $7.41 | $5,736 |
| 99214 Office E&M - Established | Office | 659 | 385 | $89.02 | $59K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 420 | 281 | $12.58 | $5,286 |
| 73130 X-ray - Upper Extremity | Office | 172 | 85 | $27.41 | $4,715 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 159 | 102 | $0.70 | $112 |
| 96372 Injection Administration | Office | 126 | 86 | $10.35 | $1,304 |
| 77080 Standard X-ray | Office | 111 | 111 | $36.37 | $4,037 |
| 99204 Office E&M - New | Office | 98 | 98 | $117.02 | $11K |
| 99213 Office E&M - Established | Office | 57 | 54 | $55.62 | $3,170 |
| 73560 X-ray - Lower Extremity | Office | 54 | 31 | $24.44 | $1,320 |
| 73630 X-ray - Lower Extremity | Office | 50 | 25 | $24.36 | $1,218 |
| 73030 X-ray - Upper Extremity | Office | 41 | 27 | $26.42 | $1,083 |
| 20610 Joint Injection | Office | 37 | 26 | $51.76 | $1,915 |
| 73565 X-ray - Lower Extremity | Office | 31 | 31 | $27.58 | $855 |
| 72110 X-ray - Spine and Pelvis | Office | 30 | 30 | $37.62 | $1,129 |
By year: 2022 $111K for 2,849 services; 2023 $105K for 2,520 services; 2024 $104K for 2,904 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 774 | 411 | $7.41 | $5,736 |
Medicare prescription drug claims, 2024
In 2024, the drug Jolanta Sobotka-Czarnecki prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,264 prescriptions and refills. In total Jolanta Sobotka-Czarnecki wrote 7,262 Medicare prescriptions that cost $14.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,264 | 3,394 | 372 | $91K |
| Methotrexate Methotrexate Sodium | 1,214 | 2,776 | 338 | $64K |
| Prednisone Generic | 566 | 1,371 | 180 | $6,955 |
| Enbrel Mini Etanercept | 433 | 447 | 47 | $3.2M |
| Humira(Cf) Pen Adalimumab | 431 | 438 | 47 | $3.1M |
| Alendronate Sodium Generic | 321 | 826 | 116 | $4,401 |
| Enbrel Sureclick Etanercept | 297 | 313 | 32 | $2.2M |
| Sulfasalazine Generic | 268 | 651 | 91 | $11K |
| Leflunomide Generic | 203 | 515 | 66 | $16K |
| Enbrel Etanercept | 199 | 206 | 21 | $1.5M |
| Orencia Clickject Abatacept | 160 | 163 | 25 | $933K |
| Folic Acid Generic | 127 | 361 | 44 | $822 |
| Leucovorin Calcium Generic | 99 | 270 | 31 | $5,550 |
| Methotrexate Sodium Methotrexate Sodium/Pf | 94 | 192 | 23 | $2,062 |
| Allopurinol Generic | 91 | 241 | 26 | $1,167 |
Brand drugs: 2,460 claims; generic drugs: 4,780 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jolanta Sobotka-Czarnecki $1,341 ($1,341 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $527.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 21 | $527 |
| Novartis Pharmaceuticals Corporation NVS | 19 | $332 |
| Amgen Inc. AMGN | 15 | $213 |
| UCB, Inc. UCB.BR | 4 | $92.51 |
| Pfizer Inc. PFE | 3 | $64.63 |
| Alexion Pharmaceuticals, Inc. AZN | 2 | $42.59 |
| Organon LLC OGN | 1 | $20.57 |
| Actelion Pharmaceuticals US, Inc. JNJ | 1 | $18.62 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $15.25 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $13.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.